INTRODUCTION: Suppression of physiological myocardial FDG activity is vital in patients undergoing PET/CT for assessment of known or suspected cardiac sarcoidosis. This study aims to evaluate the efficacy of physiological myocardial FDG suppression following a protocol change to a 24-h high fat very low carbohydrate (HFVLC) diet and prolonged fast. METHODS: A retrospective review of patients undergoing FDG PET/CT for the evaluation of cardiac sarcoidosis was performed. Prior to June-2018, patients were prepared with a single very high-fat low carbohydrate meal followed by a 12-18 h fast (group 1). After June-2018, a protocol change was initiated with patients prepared with a HFVLC diet for 24-h followed by a 12-18 h fast (group 2). Focal my...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
Objective(s): Physiological myocardial 18F-fluorodeoxyglucose (18F-FDG) uptake in oncologic positron...
Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Objectives: In this educational exhibit, we study quantitative approaches to assess adequate metabol...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
lntroduction: Cardiac positron emission tomography (PET) using F18-fluorodeoxyglucose (FDG) has been...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: FDG PET/CT with myocardial perfusion imaging is a useful method for evaluating cardiac s...
Cardiac sarcoidosis is considered to be a significant cause of advanced atrioventricular (AV) block ...
Sarcoidosis is a multisystem disorder with cardiac invol-vement in 25 % of cases [1]. Diagnosis of c...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
Objective(s): Physiological myocardial 18F-fluorodeoxyglucose (18F-FDG) uptake in oncologic positron...
Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Objectives: In this educational exhibit, we study quantitative approaches to assess adequate metabol...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
lntroduction: Cardiac positron emission tomography (PET) using F18-fluorodeoxyglucose (FDG) has been...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: FDG PET/CT with myocardial perfusion imaging is a useful method for evaluating cardiac s...
Cardiac sarcoidosis is considered to be a significant cause of advanced atrioventricular (AV) block ...
Sarcoidosis is a multisystem disorder with cardiac invol-vement in 25 % of cases [1]. Diagnosis of c...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
Objective(s): Physiological myocardial 18F-fluorodeoxyglucose (18F-FDG) uptake in oncologic positron...